Table 4.
SD | SC-β | 95% CI for SC-β | P-value | VIF | |
---|---|---|---|---|---|
CAV area (Model F ratio = 6.504, P = 0.003) | |||||
%VV | 0.93 | 0.657 | 0.319 to 1.194 | 0.003 | 1.554 |
Years after HTX | 3.57 | 0.332 | −0.071 to 0.843 | 0.092 | 1.679 |
Patient age | 12.20 | 0.086 | −0.281 to 0.488 | 0.585 | 1.202 |
Donor age | 10.72 | 0.212 | −0.151 to 0.654 | 0.211 | 1.314 |
Body mass index | 4.51 | −0.033 | −0.469 to 0.392 | 0.849 | 1.490 |
Ischaemic time | 33.61 | 0.141 | −0.202 to 0.538 | 0.362 | 1.125 |
Vasa vasorum area (Model F ratio = 3.812, P = 0.021) | |||||
%VV | 0.93 | 0.597 | 0.160 to 0.969 | 0.010 | 1.406 |
Years after HTX | 3.57 | 0.241 | −0.214 to 0.693 | 0.275 | 1.607 |
Patient age | 12.20 | 0.074 | −0.317 to 0.464 | 0.685 | 1.156 |
Donor age | 10.72 | 0.224 | −0.182 to 0.622 | 0.254 | 1.264 |
Body mass index | 4.51 | 0.077 | −0.347 to 0.541 | 0.706 | 1.412 |
Ischaemic time | 33.61 | 0.182 | −0.202 to 0.571 | 0.316 | 1.092 |
CAV, cardiac allograft vasculopathy; CI, confidence interval; HTX, heart transplantation; %VV, per cent vasa vasorum volume; SD, sample standard deviation; Δ%PV, delta per cent plaque volume; SC-β, standardized coefficients β; VIF, variance inflation factor.